Furthermore, the combination of PPARγ ligands with other drugs potentiates the pro-apoptotic effects exerted by activation of PPARγ in breast cancer, suggesting a promising role of this receptor in the multidrug approach therapy [28]. The gene discussed is PPARG; the disease is breast carcinoma.